The table below shows Eledon Pharmaceuticals, Inc.'s income statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
Line item
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
Revenue
-
-
-
-
-
-
Cost of revenue
-
-
-
-
-
-
Gross profit
-
-
-
-
-
-
R&D
$66.27M
$51.96M
$30.31M
$27.08M
$23.73M
$6.13M
SG&A
$16.98M
ELDN annual revenue (10-K history)
Eledon Pharmaceuticals, Inc. reported annual revenue of $0.00 for fiscal year 2016. Figures come from the company's audited annual reports as filed with the SEC.